However, conflicting reports on TLR3 expression in critically ill patients reflect the complexity of its role as a critical mediator of the immunoprotective and immunopathogenic consequences associated with COVID-19 (Table 2) [150,151]. This evidence concerns the gene TLR3 and COVID-19.